Danaher plans to launch an AI-powered autonomous laboratory at Abcam, combining robotics and technology from across the company to design, build and test antibodies and other molecular tools. Expected to operate at scale in early 2027, the lab aims to accelerate discovery up to eightfold and eventually produce nearly ten times more reagents, while scientists retain key decision-making roles.

Tech· 1d

Facts from Wikidata (CC0). Image by Unknown author via Wikimedia Commons (Public domain).

Abcam

Negocio del Reino Unido

0miembros1here now

Pregunta a Genius Sitio

Sitio Diario

Feed Debates Acerca de

Sort by

Content type

Últimas noticias y debate sobre Abcam

Sort by

Content type

Abcam· Tech · 10 sources · 1dStory

Danaher Plans AI Lab for Antibody Discovery in 2027

Tech· 1d

Facts from Wikidata (CC0). Image by Unknown author via Wikimedia Commons (Public domain).

Abcam across IJR

Ask Genius by OpenServe about Abcam Create in Studio Build a game Watch videos

About Abcam

Abcam Limited es un productor, distribuidor y vendedor de herramientas de investigación de proteínas que opera en todo el mundo desde 13 ubicaciones con 1.800 empleados, de los cuales 400 trabajan en Investigación y Desarrollo (I+D). Abcam cotizó en el Nasdaq y en la Bolsa de Londres hasta que fue adquirida por Danaher Corporation en 2023.

members

here now

Country: United Kingdom
Headquarters: Cambridge
Inception: 1998
Website: https://www.abcam.com/en-us

Coverage spread L13 / C31 / R56

Everything about Abcam →

Related journals

Connected

United Kingdom

Live room · 1 here

Be the first in the room — members see you arrive.

Join the room

Related journals

Connected

United Kingdom

Abcam across IJR

Ask Genius by OpenServe about Abcam Create in Studio Build a game Watch videos